BRCA2 and breast cancer: In this work, we have carried out one of the most comprehensive studies of the correlation between aberrant splicing and breast cancer, whereby we evaluated the impact on splicing of 52 DNA variants of BRCA2 exons 17 and 18 with the stable seven-exon minigene MGBR2_ex14-20.